{"filing":{"accession_number":"0001575872-26-000585","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-08-17","report_date":"2026-08-14","primary_document":"rdy0937_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000585/rdy0937_6k.htm"},"events":[{"id":28084,"run_id":25668,"accession_number":"0001575872-26-000585","anchor_item_number":"EX-99.1","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"summary":"The disclosure reports the outcome of a USFDA GMP inspection at Dr. Reddy's API manufacturing facility in the UK, classified as \"Voluntary Action Indicated (VAI)\" with the inspection officially closed. This is a regulatory matter involving a foreign regulatory agency (USFDA) and a manufacturing facility, which could affect product quality, compliance standing, and market access. While VAI is not the most severe classification, it signals regulatory findings requiring corrective action and is material to investors assessing operational and regulatory risk.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-08-17","form":"6-K","submitted_at":null,"items":[{"id":29888,"accession_number":"0001575872-26-000585","item_number":"EX-99.1","item_title":"rdy0937_ex99-1.htm","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"reasoning":"The disclosure reports the outcome of a USFDA GMP inspection at Dr. Reddy's API manufacturing facility in the UK, classified as \"Voluntary Action Indicated (VAI)\" with the inspection officially closed. This is a regulatory matter involving a foreign regulatory agency (USFDA) and a manufacturing facility, which could affect product quality, compliance standing, and market access. While VAI is not the most severe classification, it signals regulatory findings requiring corrective action and is material to investors assessing operational and regulatory risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:48.297143+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29888,"accession_number":"0001575872-26-000585","item_number":"EX-99.1","item_title":"rdy0937_ex99-1.htm","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"reasoning":"The disclosure reports the outcome of a USFDA GMP inspection at Dr. Reddy's API manufacturing facility in the UK, classified as \"Voluntary Action Indicated (VAI)\" with the inspection officially closed. This is a regulatory matter involving a foreign regulatory agency (USFDA) and a manufacturing facility, which could affect product quality, compliance standing, and market access. While VAI is not the most severe classification, it signals regulatory findings requiring corrective action and is material to investors assessing operational and regulatory risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-17T11:56:48.297143+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-08-17"}]}